In vitro anticancer, antioxidant, antimicrobial, antileishmanial, enzymes inhibition and in vivo anti-inflammatory activities of organotin(IV) derivatives of 4-bromophenoxyacetic acid

Organotin(IV) derivatives {(n-C4H9)3SnL (1), (CH3)3SnL (2), (n-C4H9)2SnL2 (3) and (CH3)2SnL2 (4)} of 4-bromophenoxyacetic acid (HL) were synthesized and characterized by elemental, FT-IR, NMR and single crystal XRD diffraction analyses. The carboxylate ligand showed bridging/chelating bidentate coordination. The complexes 1 and 2 have adopted polymeric chain structures consisting tin atoms in distorted trigonal bipyramidal geometry. Complex 3 has shown highest DPPH radical scavenging (IC50 = 33.46 µg/mL) and antileishmanial activity (IC50 = 27.06 µg/mL). Complex 3 was also the most efficient agent in acetylcholinesterase (IC50 = 5.12 µg/mL), butyrylcholinesterase (IC50 = 13.79 µg/mL) and Monoamine oxidase (IC50 = 8.50 µg/mL) inhibition assays. Complex 4 (IC50 = 18.73 µg/mL) was the most potent ABTS radical scavenger. Complex 1 with IC50 values of 27.50 and 71.32 µg/mL was the most efficient α-glucosidase and dipeptidyl peptidase-4 enzyme inhibitor, respectively. While complex 2 was found the most potent Cyclooxygenase-2 (7.81 µg/mL) and 5-Lioxygenase (6.69 µg/mL) inhibitor. MTT assay revealed highest inhibitory potency of complexes 4 (IC50 = 8.035 ± 0.05 μg/ml), and 1 (IC50 = 10.16±0.17μg/ml) towards the brain cancer cell line. The in vivo study performed on mice have shown potent anti-inflammatory effects of 1 and 2 comparable to the standard, indomethacin.